Medicare Weighing Changes to Doctor Drug Payments, Memo Shows

The U.S. is mulling changes to how the Medicare program pays physicians for administering expensive cancer drugs and other medications given in doctors’ offices, according to a memo from the Centers for Medicare and Medicaid Services.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.